Pimecrolimus

inquiry

Cat No.

CEI-1025

Description

Pimecrolimus, a rapamycin (sirolimus) derivative, is a cell-selective inhibitor of inflammatory cytokines developed for the treatment of inflammatory skin diseases, such as allergic contact dermatitis, atopic dermatitis, plaque-type psoriasis, and irritant contact dermatitis. It reduces the production of inflammatory cytokines in T cells and mast cells and inhibits the release of preformed inflammatory mediators from mast cells.

Abbr

Pimecrolimus(Cytokine)

Appearance

white crystalline powder.

CAS_No

137071-32-0

Molecular Weight

810.4 Da

Purity

>99%

Stability

Store at or below –20°C. Solid form is stable at least 12 months from date of receipt, when stored as directed. Do not store aqueous solutions for more than one day.

Synonyms

Elidel, SDZ-ASM-981

Targets

Cytokine

Molecular Formula

C43H68ClNO11

Solubility

Soluble in DMSO and ethanol, up to about 25 mg/ml

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry